| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Aquilo Capital Management, LLC is a 10% Owner at PVLA, with reported holdings spanning 2 companies. Recent filings cover 27 purchases and 14 sales. Those positions are worth an estimated $18.5M at current prices.
Our model assigns Aquilo Capital Management, LLC a below-average insider score of 33/100, based on 25 past trades. Over a 12-month horizon, 4.0% of those trades were profitable, with an average 12-month return of -83.3%.
Aquilo Capital Management, LLC's largest disclosed position is in PVLA as 10% Owner, worth about $10.8M. The recent filings there lean toward selling, a net 1,900,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2022 | SPRO Spero Therapeutics, Inc. | 10% Owner | Sell | 1,901,796 | $2.25 | $4,279,611.54 | -35.7% | -26.4% | -45.0% | |
| Apr 26, 2022 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 39,727 | $5.24 | $207,970.85 | +0.8% | -85.0% | -67.0% | |
| Mar 30, 2022 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 50,000 | $8.79 | $439,420.00 | +1.0% | -91.0% | -83.3% | |
| Mar 14, 2022 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 23,708 | $7.63 | $180,797.21 | +0.5% | -87.2% | -81.5% | |
| Feb 28, 2022 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 44,833 | $9.53 | $427,227.11 | +0.9% | -87.7% | -84.6% | |
| Feb 18, 2022 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 14,828 | $9.24 | $137,038.89 | +0.3% | -84.4% | -81.5% | |
| Jan 31, 2022 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 125,000 | $11.59 | $1,448,262.50 | +2.5% | -57.1% | -84.4% | |
| Jan 24, 2022 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 1,599 | $10.89 | $17,418.07 | - | -52.7% | -84.2% | |
| Jan 18, 2022 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 48,488 | $12.41 | $601,963.97 | +1.0% | -54.5% | -84.9% | |
| Jan 10, 2022 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 8,867 | $12.93 | $114,608.64 | +0.2% | -48.7% | -85.7% |